BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$462M |
| 2 |
UnitedHealth
UNH
|
+$441M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$429M |
| 4 |
Analog Devices
ADI
|
+$347M |
| 5 |
Apple
AAPL
|
+$342M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.7B |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$536M |
| 3 |
Netflix
NFLX
|
+$316M |
| 4 |
PepsiCo
PEP
|
+$293M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$206M |
Sector Composition
| 1 | Technology | 25.21% |
| 2 | Financials | 10.94% |
| 3 | Healthcare | 10.54% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Altimmune
ALT
$322M
| $24.2K | ﹤0.01% |
4,842
-3,314
| -41% | -$16.6K |
|
3477
Invesco Mortgage Capital
IVR
$501M
| $24.1K | ﹤0.01% |
3,051
-3,183
| -51% | -$25.1K |
|
|
FBLA
3478
FB Bancorp, Inc. Common Stock
FBLA
$222M
| $24.1K | ﹤0.01% |
+2,136
| New | +$24.1K |
|
3479
Zevra Therapeutics
ZVRA
$412M
| $24K | ﹤0.01% |
3,204
-3,142
| -50% | -$23.5K |
|
3480
Amplify Transformational Data Sharing ETF
BLOK
$1.27B
| $24K | ﹤0.01% |
650
-1,103
| -63% | -$40.7K |
|
3481
Immunome
IMNM
$823M
| $23.9K | ﹤0.01% |
3,555
-3,029
| -46% | -$20.4K |
|
3482
OmniAb
OABI
$233M
| $23.9K | ﹤0.01% |
9,958
-7,591
| -43% | -$18.2K |
|
3483
Covenant Logistics
CVLG
$582M
| $23.9K | ﹤0.01% |
1,075
-4,011
| -79% | -$89K |
|
3484
Tourmaline Bio
TRML
$1.23B
| $23.8K | ﹤0.01% |
1,568
-1,803
| -53% | -$27.4K |
|
3485
Clearwater Paper
CLW
$350M
| $23.6K | ﹤0.01% |
929
-10,165
| -92% | -$258K |
|
|
OPRA
3486
Opera Ltd
OPRA
$1.79B
| $23.5K | ﹤0.01% |
1,475
-6,740
| -82% | -$107K |
|
3487
Humacyte
HUMA
$246M
| $23.4K | ﹤0.01% |
13,714
-899
| -6% | -$1.53K |
|
3488
Usana Health Sciences
USNA
$553M
| $23.3K | ﹤0.01% |
864
-18,552
| -96% | -$500K |
|
3489
Artesian Resources
ARTNA
$337M
| $23.2K | ﹤0.01% |
712
-4,578
| -87% | -$149K |
|
3490
Nuvation Bio
NUVB
$1.09B
| $23.2K | ﹤0.01% |
13,163
-10,868
| -45% | -$19.1K |
|
|
AVR
3491
Anteris Technologies Global Corp. Common Stock
AVR
$211M
| $23.2K | ﹤0.01% |
+6,361
| New | +$23.2K |
|
|
EBTC
3492
DELISTED
Enterprise Bancorp
EBTC
| $23K | ﹤0.01% |
592
-8,625
| -94% | -$336K |
|
3493
MeiraGTx Holdings
MGTX
$600M
| $22.7K | ﹤0.01% |
3,344
-2,653
| -44% | -$18K |
|
3494
Bowman Consulting
BWMN
$718M
| $22.7K | ﹤0.01% |
1,038
-653
| -39% | -$14.3K |
|
3495
Clear Channel Outdoor Holdings
CCO
$651M
| $22.6K | ﹤0.01% |
20,357
-36,881
| -64% | -$40.9K |
|
3496
RCI Hospitality Holdings
RICK
$300M
| $22.5K | ﹤0.01% |
523
-590
| -53% | -$25.3K |
|
3497
Alerus Financial
ALRS
$565M
| $22.4K | ﹤0.01% |
1,211
-1,688
| -58% | -$31.2K |
|
3498
Lionsgate Studios Corp.
LION
$2.07B
| $22.2K | ﹤0.01% |
+2,974
| New | +$22.2K |
|
3499
iShares MSCI ACWI Low Carbon Target ETF
CRBN
$1.07B
| $22.2K | ﹤0.01% |
116
-782
| -87% | -$150K |
|
3500
Kodak
KODK
$488M
| $22K | ﹤0.01% |
3,484
-4,480
| -56% | -$28.3K |
|